The International Glaucoma Association (IGA) and Santen UK Ltd. launch an educational series of films to help people understand glaucoma.

13 September 2019
Source: The International Glaucoma Association

The films feature leading experts in the field of ophthalmology who provide clear information about glaucoma sight loss, how it is detected, monitored and managed. Commenting on the series, the IGA says: “This is a comprehensive set of films which we hope will walk people through what glaucoma is, what to expect from the tests, what help is available and

Read more The International Glaucoma Association (IGA) and Santen UK Ltd. launch an educational series of films to help people understand glaucoma.

Fight for Sight: Examining the role of vitamin B3 supplementation in reducing and preventing retinal cell damage caused by glaucoma

20 August 2019

Fight for Sight is funding researchers at Cardiff University to examine the extent to which dietary supplementation of Nicotinamide – a form of vitamin B3 – can be used to reduce, and even prevent, retinal damage caused by glaucoma. This important research could help pave the way for new types of treatment for glaucoma, which are currently focused only on

Read more Fight for Sight: Examining the role of vitamin B3 supplementation in reducing and preventing retinal cell damage caused by glaucoma

New molecular ‘scaffolding’ could repair nerve damage in glaucoma

Fight for Sight logo

16 July 2019
Source: Fight for Sight

Fight for Sight is funding scientists at the University of Cambridge to research how a new ‘molecular scaffolding’ could help restore vital nerve connections between the eye and the brain, potentially recovering the sight loss caused by glaucoma and other conditions, and even paving the way for future eye transplants. Professor Keith Martin, Professor James Fawcett and team will be

Read more New molecular ‘scaffolding’ could repair nerve damage in glaucoma

‘Organ-on-a-chip’ opens the door to new treatment for glaucoma and other eye diseases

Fight for Sight logo

24 May 2019
Source: Fight for Sight

Eye research charity, Fight for Sight, is funding the development of an ‘organ-on-chip’ that for the first time will be used to help investigate glaucoma, a leading cause of blindness. Dr Darryl Overby and Dr Sam Au from Imperial College London, in collaboration with Massachusetts Institute of Technology (MIT) and Duke University, will build upon the latest bioengineering technology to

Read more ‘Organ-on-a-chip’ opens the door to new treatment for glaucoma and other eye diseases

Scottish Muslims urged to take care of eye health during Ramadan

RNIB logo

3 May 2019
Source: RNIB Scotland

Scottish Muslims are being urged to be aware of their eye health when fasting during the religious month of Ramadan, which starts this weekend. Throughout Ramadan Muslims abstain from eating and drinking during daylight hours. Gozie JoeAdigwe of sight loss charity RNIB Scotland said: “People from some ethnic minority communities can be more vulnerable to some eye conditions, so it

Read more Scottish Muslims urged to take care of eye health during Ramadan

The International Glaucoma Association (IGA) and Santen Produce Unique ‘Eye Test’ for World Glaucoma Awareness Week

14 March 2019
Source: International Glaucoma Association

The International Glaucoma Association (IGA) and specialist ophthalmology company Santen Pharmaceutical Co Ltd, have joined forces to produce a unique interactive ‘eye test’ to demonstrate what the world looks like to people living with glaucoma. The test is part of a joint campaign to raise awareness of the eye condition among younger first-degree relatives of older people most likely to

Read more The International Glaucoma Association (IGA) and Santen Produce Unique ‘Eye Test’ for World Glaucoma Awareness Week

NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

21 November 2018
Source: NIHR

• 76 per cent of hospitals in England now offer patients the opportunity to take part in eye disease studies • 15,500 patients per year offered innovative treatments for diseases such as age-related macular degeneration • Ophthalmology community ‘punching above its weight’ in world of research A new paper published today highlights how some 76 per cent of hospitals in

Read more NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

Fight for Sight: Charity announces research into personalised glaucoma treatment on World Sight Day 2018

11 October 2018
Source: Fight for Sight

Fight for Sight has chosen World Sight Day 2018 (11 October) to announce funding for a research project that will develop personalised medicine for patients at risk of glaucoma from steroid use. Professor Colin Willoughby from Ulster University has been awarded a £170,000 project grant over three years to better understand the genetic basis for steroid-induced eye pressure. The aim

Read more Fight for Sight: Charity announces research into personalised glaucoma treatment on World Sight Day 2018

Serious eye disorders. Consultation on draft quality standard, joint submisison from The Royal College of Ophthalmologists with The College of Optometrists and Vision UK

2 October 2018

This quality standard will cover the diagnosis and management of serious eye conditions in adults including cataracts, glaucoma and macular degeneration. It will also cover preventing sight loss in adults. This quality standard will replace the existing NICE quality standard for Glaucoma in adults (QS7). The topic was identified for update following the annual review of quality standards in 2017.

Read more Serious eye disorders. Consultation on draft quality standard, joint submisison from The Royal College of Ophthalmologists with The College of Optometrists and Vision UK
NICE QS Chronic Disease Joint Response With RCOphth COO And Vision UK V1.4
NICE QS Chronic Disease Joint Response With RCOphth COO And Vision UK V1.4
Download pdf 0.7 MB

Optometry Today: New glaucoma treatment trialled in Manchester

9 August 2018
Source: Optometry Today

The patients at Manchester Royal Eye Hospital are the first in the UK to trial the eyeWatch surgical implant. The eyeWatch is a new fully adjustable surgical implant that drains excess eye fluid that is caused by glaucoma. It is the first ever glaucoma device that enables post-operative flow adjustment in the clinic. The eyeWatch, which is manufactured by Rheon

Read more Optometry Today: New glaucoma treatment trialled in Manchester